<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02221141</url>
  </required_header>
  <id_info>
    <org_study_id>Fabry Disease Cardioscreening</org_study_id>
    <nct_id>NCT02221141</nct_id>
  </id_info>
  <brief_title>Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laurence Gabriel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dinant Godinne - UCL Namur</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the prevalence in Belgium of Fabry disease in
      patients with unexplained hypertrophic cardiomyopathy measured by echocardiography and to
      determine in Fabry patients which was the most frequently initial symptom.

      Actually the early diagnosis is important because a treatment exists that can prevent future
      complications.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients with left ventricular hypertrophy who have Fabry Disease mutation</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Left Ventricular Hypertrophy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with left ventricular hypertrophy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  unexplained left ventricular hypertrophy

        Exclusion Criteria:

          -  isolated septal hypertrophy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laurence Gabriel</last_name>
    <phone>+32 81 42 21 11</phone>
    <phone_ext>3623</phone_ext>
    <email>laurence.gabriel@uclouvain.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Karine Jourdan</last_name>
    <phone>+32 81 42 21 11</phone>
    <phone_ext>3610</phone_ext>
    <email>karine.jourdan@uclouvain.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Dinant-Godinne</name>
      <address>
        <city>Yvoir</city>
        <zip>5530</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Laurence Gabriel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2014</study_first_submitted>
  <study_first_submitted_qc>August 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 20, 2014</study_first_posted>
  <last_update_submitted>January 31, 2018</last_update_submitted>
  <last_update_submitted_qc>January 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Dinant Godinne - UCL Namur</investigator_affiliation>
    <investigator_full_name>Laurence Gabriel</investigator_full_name>
    <investigator_title>Dr Laurence GABRIEL</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertrophy</mesh_term>
    <mesh_term>Hypertrophy, Left Ventricular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

